Tandym Group, the leader in specialized solutions for the healthcare, life sciences, technology and professional services industries, today announced its acquisition of Entitech Solutions, a leading provider of tailored solutions for healthcare and life sciences organizations.
“We are excited to welcome the talented team at Entitech Solutions to the Tandym family,” said Byrne Mulrooney, CEO of Tandym Group. “Acquiring Entitech aligns with our vision to broaden our service portfolio and extend the capabilities of Tandym Catalyst™, our AI-enabled technology platform.”
The acquisition of Entitech represents Tandym’s continued commitment to expanding its service portfolio to provide comprehensive workforce and technology solutions. Entitech brings specialized expertise in strategy, clinical data harmonization, and system integration services to pharmaceutical and biotech companies.
A provider of innovative technology services, Entitech helps companies meet process optimization goals at a fraction of the cost by simplifying technology and making existing systems work better. Pharmaceutical companies benefit from Entitech’s ability to implement both clinical and regulatory data hubs with flexible integration architectures that connect directly to site Electronic Medical Records (EMR) systems and existing data warehouse capabilities.
“I’m thrilled about the integration of Entitech into Tandym,” said Michelle Keefe, Non-Executive Director with Tandym Group. “This strategic move represents a significant step forward in our ability to deliver integrated solutions to the healthcare and life sciences industries. We’re creating new opportunities for innovation and growth that I’m genuinely excited to see unfold.”
Recognized globally for its deep expertise in Structured Component Authoring (SCA), Entitech built its substantial reputation leveraging SCA to deliver on upcoming regulatory requirements such as Electronic Medicinal Product Information (ePI) and Identification of Medicinal Products (IDMP). Entitech is also working with customers on how to leverage structured content as the backbone for AI/Content Generation solutions.
“Joining Tandym Group represents an exciting opportunity for our team and clients,” said John Jones, CEO of Entitech Solutions. “Tandym’s extensive resources and investment in the Tandym Catalyst™ platform will enable us to accelerate growth and provide greater value to healthcare and life sciences companies.”
Tandym Group is backed by Mill Rock Capital, a growth and operations-oriented private investment firm, and ICG, a global alternative asset manager. Akin Gump Strauss Hauer & Feld LLP served as legal advisor to Tandym.
